Topic:

Infectious Diseases

Latest Headlines

Latest Headlines

GSK anonymously listens to online vax talk, then mines data for nuggets

GlaxoSmithKline has used a text analytics model to analyze public discussion boards in an attempt to assess patient sentiment about vaccines and glean insights into why vaccine fears persist despite clinical evidence of their safety.

Takeda takes on Sanofi with $250M dengue buyout

In 1977, dengue fever experts predicted a vaccine could be ready in 10 years. That prediction proved wildly optimistic, leaving the 2.5 billion people at risk from dengue fever without protection. Sanofi is at the forefront of dengue vaccine research but now faces a challenger from Japan.

GSK, Sanofi vaccines proving effective in measles outbreak

The vaccine for measles, mumps and rubella (MMR) has proven an effective tool in the past. In 2008, a U.K. study found one dose protects 95% of people against measles, with the follow-up shot immunizing most of the remaining 5%. Now similar data is emerging from Wales.

U.K. vaccine expansion a boon for GSK and Merck

Sales of GlaxoSmithKline's rotavirus vaccine Rotarix and Merck's shingles vaccine Zostavax will be buoyed by their inclusion on the U.K. national immunization schedule.

Possible measles-related death in Wales as outbreak spreads

The measles outbreak in Wales has now infected almost 900 people--with 121 cases coming in the past week--and may have caused its first death.

China's response to H7N9 earns WHO praise

While Chinese officials faced some criticism for a perceived delay in announcing last month's H7N9 outbreak, positive sentiments from global health officials have far outweighed the negative comments, in sharp contrast to the SARS outbreak a decade ago.

Pfizer's Prevnar 13, GSK's Synflorix pump up vaccination cost

BIO and the International Federation of Pharmaceutical Manufacturers & Associations warn that more funding is needed to maintain current immunization rates while adding new vaccines to programs.

No link between vaccines and Guillain-Barré in big study

Alleged links between vaccines and the nerve-degenerative disorder Guillain-Barré are among vaccine safety fears. A new study shows that any link between them is not strong enough to outweigh the benefits of vaccines.

Vaccine choices swayed by social networks

A U.S. study has shown the importance of people's social networks in vaccination choices, with the presence of anti-immunization friends correlating with parents deciding against giving shots.

Polio eradication push nearing endgame again

A recent decline of polio cases has emboldened scientists to again set a target for eradication of polio. More than 400 scientists from 80 countries have signed up in support of a plan to end polio by 2018.